Events Partner Content 14th Annual RNA Therapeutics Conference RNA / 8 - 9 February 2023 / London, UK
Partner Content Partner Content Official Invitation from Chair of RNA Therapeutics 2019 Conf... Invitation from Chair of RNA Therapeutics 2019
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.